基本信息
-
(1R,2R)-1,2-双(甲磺酰基氧基甲基)环己烷
-
186204-35-3
-
(1R,2R)-1,2-环己烷二甲醇二甲磺酸酯
-
C10H20O6S2
-
300.39200
-
[(1R,2R)-2-(methylsulfonyloxymethyl)cyclohexyl]methyl methanesulfonate
-
1308068-626-2
-
1.27
-
(R,R)-1,2-Bis(Methanesulphonyloxymethyl)cyclohexane;(R)-trans-1,2-bis-methanesulfonyloxymethyl-cyclohexane;(R,R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane;(1R,2R)-(-)-trans-cyclohexane-1,2-diylbis(methylene)dimethanesulfonate;(1R,2R)-cyclohexane-1,2-diyldimethanediyl dimethanesulfonate;trans-1,2-(1R,2R)-bis(methanesulfonyloxymethyl)cyclohexane;methanesulfonic acid 2-methanesulfonyloxymethyl-cyclohexylmethyl ester;trans-(R,R)-1,2-bis(methanesulfonylmethyl)cyclohexane;(R)-trans-1,2-Bis-methansulfonyloxymethyl-cyclohexan;查看更多英文别名收起
-
253.339ºC
-
-
495.284ºC at 760 mmHg
-
详细信息
英文名称: (R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
中文名称: (R,R)-1,2-双(甲磺酰基氧基甲基)环己烷
MF: C10H20O6S2
MW: 300.394
CAS: 186204-35-3
公司简介
北京捷瑞斯医药科技有限公司(简称“捷瑞斯医药”),是一家专业生产销售医药中间体的厂家, 目前在产产品为西尼必利中间体,加雷沙星中间体,芬戈莫德中间体,卢非酰胺中间体,托伐普坦中间体,多佐胺中间体,卡立普多中间体,阿齐沙坦中间体,鲁拉西酮中间体,艾普拉唑中间体
,度洛西汀中间体等。公司一贯坚持“质量,用户至上,优质服务,信守合同”的宗旨,高质量的产品,良好的信誉,优质的服务,竭诚与国内外商家双赢合作,共同发展,共创辉煌!